bf/NYSE:AVNS_icon.jpeg

NYSE:AVNS

Avanos Medical, Inc.

  • Stock

USD

Last Close

19.47

10/05 20:00

Market Cap

889.51M

Beta: 0.93

Volume Today

133.89K

Avg: 242.17K

PE Ratio

−15.55

PFCF: 23.35

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
154.60M
-
27.10M
82.47%
-426.30M
1,673.06%
39.80M
109.34%
79.30M
99.25%
57.50M
27.49%
-45.90M
179.83%
-27.20M
40.74%
5.20M
119.12%
50.50M
871.15%
-9.90M
119.60%
depreciation and amortization
69.20M
-
85.40M
23.41%
65.40M
23.42%
65.20M
0.31%
59.50M
8.74%
33.50M
43.70%
36.90M
10.15%
42.90M
16.26%
38.30M
10.72%
47.70M
24.54%
46.10M
3.35%
deferred income tax
-900K
-
-35M
3,788.89%
8.20M
123.43%
-11.50M
240.24%
-6.20M
46.09%
3.70M
159.68%
-6.50M
275.68%
25.90M
498.46%
-3.40M
113.13%
-6.60M
-
stock based compensation
6M
-
7.90M
31.67%
14.10M
78.48%
14.80M
4.96%
12.60M
14.86%
10.50M
16.67%
10.50M
0%
12.10M
15.24%
13.20M
9.09%
15.90M
20.45%
15.80M
0.63%
change in working capital
-11.90M
-
12.80M
207.56%
-17M
232.81%
91.60M
638.82%
-4.30M
104.69%
-143.40M
3,234.88%
-59.60M
58.44%
-67.80M
13.76%
26M
138.35%
-24.30M
193.46%
-18M
25.93%
accounts receivables
-19.50M
-
15.10M
177.44%
9M
40.40%
8.40M
6.67%
-15.30M
282.14%
67.40M
540.52%
-800K
101.19%
45.80M
5,825%
-10.80M
123.58%
-24.70M
128.70%
39M
257.89%
inventory
14.30M
-
-2.90M
120.28%
-20.20M
596.55%
41M
302.97%
-16.80M
140.98%
-34.50M
105.36%
-21.30M
38.26%
-21.80M
2.35%
17.20M
178.90%
-30.90M
279.65%
4.70M
115.21%
accounts payables
15.10M
-
4.50M
70.20%
14.70M
226.67%
6.50M
55.78%
18.80M
189.23%
-64M
440.43%
-83.60M
30.63%
-18.90M
77.39%
-11.90M
37.04%
35.40M
397.48%
-14.40M
140.68%
other working capital
-21.80M
-
-3.90M
82.11%
-20.50M
425.64%
35.70M
274.15%
9M
74.79%
-112.30M
1,347.78%
46.10M
141.05%
-72.90M
258.13%
31.50M
143.21%
-4.10M
113.02%
-47.30M
1,053.66%
other non cash items
6.80M
-
49.70M
630.88%
453.20M
811.87%
-11.10M
102.45%
3.30M
129.73%
-107.40M
3,354.55%
-9.90M
90.78%
11.60M
217.17%
8M
31.03%
1.10M
86.25%
5.00M
354.55%
net cash provided by operating activities
223.80M
-
147.90M
33.91%
97.60M
34.01%
188.80M
93.44%
144.20M
23.62%
-145.60M
200.97%
-74.50M
48.83%
-2.50M
96.64%
87.30M
3,592%
90.90M
4.12%
32.40M
64.36%
investments in property plant and equipment
-49M
-
-78.50M
60.20%
-70.40M
10.32%
-29.10M
58.66%
-43.20M
48.45%
-49.10M
13.66%
-50.60M
3.05%
-20.20M
60.08%
-21M
3.96%
-19.30M
8.10%
-17.80M
7.77%
acquisitions net
-2.20M
-
-175M
-
688.60M
-
-57.50M
108.35%
-4M
93.04%
-116.10M
-
39.40M
133.94%
purchases of investments
-2.20M
-
sales maturities of investments
49M
-
other investing activites
-46.50M
-
7.80M
116.77%
7.80M
0%
3.20M
58.97%
100K
96.88%
net cash used for investing activites
-50.90M
-
-70.70M
38.90%
-62.60M
11.46%
-200.90M
220.93%
-43.10M
78.55%
639.50M
1,583.76%
-108.10M
116.90%
-24.20M
77.61%
-21M
13.22%
-135.40M
544.76%
21.60M
115.95%
debt repayment
-67.90M
-
-13.80M
79.68%
-51M
269.57%
-72M
41.18%
-339M
-
-200K
99.94%
-254.80M
127,300%
-70M
72.53%
-296.60M
323.71%
-64.70M
78.19%
common stock issued
5.30M
-
3.40M
35.85%
6.20M
82.35%
1.70M
72.58%
1.30M
23.53%
common stock repurchased
-1M
-
-900K
10%
-2.50M
177.78%
-900K
64%
-3.60M
300%
-900K
75%
-11.50M
1,177.78%
-45.50M
295.65%
-19.10M
58.02%
dividends paid
-680M
-
-5.30M
-
-3.40M
35.85%
-6.20M
82.35%
-1.70M
72.58%
other financing activites
-112.10M
-
723M
744.96%
1.40M
99.81%
71.50M
5,007.14%
4.70M
93.43%
15.50M
229.79%
5.30M
65.81%
185.70M
3,403.77%
26.20M
85.89%
398.80M
1,422.14%
-11.70M
102.93%
net cash used provided by financing activities
-180M
-
29.20M
116.22%
-50.60M
273.29%
-1.40M
97.23%
2.20M
257.14%
-324.40M
14,845.45%
1.50M
100.46%
-70M
4,766.67%
-55.30M
21%
56.70M
202.53%
-94.20M
266.14%
effect of forex changes on cash
3.30M
-
-1.50M
145.45%
-3.90M
160%
-2.30M
41.03%
2.70M
217.39%
-4.70M
274.07%
1.90M
140.43%
2.90M
52.63%
-4M
237.93%
-3M
25%
200K
106.67%
net change in cash
-3.80M
-
104.90M
2,860.53%
-19.50M
118.59%
-15.80M
18.97%
106M
770.89%
164.80M
55.47%
-179.20M
208.74%
-93.80M
47.66%
7M
107.46%
9.20M
31.43%
-40M
534.78%
cash at beginning of period
47.90M
-
44.10M
7.93%
149M
237.87%
129.50M
13.09%
113.70M
12.20%
219.70M
93.23%
384.50M
75.01%
205.30M
46.61%
111.50M
45.69%
118.50M
6.28%
127.70M
7.76%
cash at end of period
44.10M
-
149M
237.87%
129.50M
13.09%
113.70M
12.20%
219.70M
93.23%
384.50M
75.01%
205.30M
46.61%
111.50M
45.69%
118.50M
6.28%
127.70M
7.76%
87.70M
31.32%
operating cash flow
223.80M
-
147.90M
33.91%
97.60M
34.01%
188.80M
93.44%
144.20M
23.62%
-145.60M
200.97%
-74.50M
48.83%
-2.50M
96.64%
87.30M
3,592%
90.90M
4.12%
32.40M
64.36%
capital expenditure
-49M
-
-78.50M
60.20%
-70.40M
10.32%
-29.10M
58.66%
-43.20M
48.45%
-49.10M
13.66%
-50.60M
3.05%
-20.20M
60.08%
-21M
3.96%
-19.30M
8.10%
-17.80M
7.77%
free cash flow
174.80M
-
69.40M
60.30%
27.20M
60.81%
159.70M
487.13%
101M
36.76%
-194.70M
292.77%
-125.10M
35.75%
-22.70M
81.85%
66.30M
392.07%
71.60M
7.99%
14.60M
79.61%

All numbers in USD (except ratios and percentages)